tiprankstipranks
Trending News
More News >
Biogen (BIIB)
NASDAQ:BIIB
US Market
Advertisement

Biogen (BIIB) Technical Analysis

Compare
4,957 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Biogen’s (BIIB) Moving Averages Convergence Divergence (MACD) indicator is 1.42, suggesting Biogen is a Buy.
Biogen’s (BIIB) 20-Day exponential moving average is 147.44, while Biogen’s (BIIB) share price is $149.61, making it a Buy.
Biogen’s (BIIB) 50-Day exponential moving average is 143.95, while Biogen’s (BIIB) share price is $149.61, making it a Buy.

Biogen (BIIB) Pivot Points

Oct 31, 2025, 08:36 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
144.59
146.06
146.96
148.44
149.34
150.81
151.71
Fibonacci
146.06
146.97
147.53
148.44
149.34
149.90
150.81
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biogen (BIIB) Moving Averages

Oct 31, 2025, 08:36 AM
Period
Simple
Exponential
MA5
149.38Buy
148.97Buy
MA10
148.06Buy
148.40Buy
MA20
148.49Buy
147.44Buy
MA50
144.05Buy
143.95Buy
MA100
137.30Buy
140.31Buy
MA200
135.16Buy
140.86Buy
Biogen’s (BIIB) 10-Day exponential moving average is 148.40, while Biogen’s (BIIB) share price is $149.61, making it a Buy.
Biogen’s (BIIB) 100-Day exponential moving average is 140.31, while Biogen’s (BIIB) share price is $149.61, making it a Buy.
Biogen’s (BIIB) stock price is $149.61 and Biogen’s (BIIB) 50-day simple moving average is 144.05, creating a Buy signal.
Biogen’s (BIIB) stock price is $149.61 and Biogen’s (BIIB) 100-day simple moving average is 137.30, creating a Buy signal.
Biogen’s (BIIB) stock price is $149.61 and Biogen’s (BIIB) 200-day simple moving average is 135.16, creating a Buy signal.

Biogen (BIIB) Technical Indicators

Oct 31, 2025, 08:36 AM
Name
Value
Implied Action
RSI (14)
56.21
Neutral
STOCH (9,6)
67.93
Neutral
STOCHRSI (14)
67.40
Neutral
MACD (12,26)
1.42
Buy
ADX (14)
20.62
Neutral
Williams %R
-29.38
Buy
CCI (14)
-25.39
Neutral
ATR (14)
4.63
-
Ultimate Oscillator
58.73
Neutral
ROC
2.07
Buy
Biogen’s (BIIB) Relative Strength Index (RSI) is 56.21, creating a Neutral signal.
Biogen’s (BIIB) Trend Strength Indicator (ADX) is 20.62, creating a Neutral signal.
Biogen’s (BIIB) Commodity Channel Index (CCI) is -25.39, creating a Neutral signal.
Biogen’s (BIIB) Price Rate of Change (ROC) is 2.07, creating a Buy signal.

FAQ

Is BIIB a Buy, Hold, or Sell?
Based on BIIB’s technical indicators, BIIB is a Strong Buy.
    What is BIIB’s RSI (14)?
    BIIB’s RSI (14) is 56.21, which suggests BIIB is a Neutral.
      What is BIIB’s MACD?
      BIIB’s MACD is 1.42, which suggests BIIB is a Buy.
        What is BIIB’s 5-day moving average?
        BIIB’s 5-day moving average is 149.38, which suggests BIIB is a Buy.
          What is BIIB’s 20-day moving average?
          BIIB 20-day moving average is 148.49, which suggests BIIB is a Buy.
            What is BIIB’s 50-day moving average?
            BIIB’s 50-day moving average is 144.05, which suggests BIIB is a Buy.
              What is BIIB’s 200-day moving average?
              BIIB’s 200-day moving average is 135.16, which suggests BIIB is a Buy.
                What is BIIB’s Williams % R (14)?
                BIIB’s Williams % R (14) is -29.38, which suggests BIIB is a Buy.
                  What is BIIB’s CCI (14)?
                  BIIB’s CCI (14) is -25.39, which suggests BIIB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis